Auris Medical Receives FDA Guidance at Type C Meeting for AM-111 in the Treatment of Sudden Sensorineural Hearing Loss Pharmaceutical Investing
Cynata CYP-001 Stem Cell Therapy Meets All Safety and Efficacy Endpoints in Phase 1 Trial in GvHD Pharmaceutical Investing
Isodiol International Inc. Appoints Marvin Washington to Its Board of Directors Cannabis Investing News
Antibe Provides Scientific Report on Its Recently Completed Phase 2B Study Showing Unequivocal Gastrointestinal Safety of ATB-346 Pharmaceutical Investing
NanoSphere Health Sciences Team Among Top Industry Experts to Speak at Second Annual Grow Up Cannabis Conference and Expo Biotech Investing
